查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1787868

大肠桿菌检测市场预测（至 2032 年）：按产品、检测类型、技术、最终用户和地区进行的全球分析

E-coli Testing Market Forecasts to 2032 - Global Analysis By Product (Consumables, Instruments, and Other Products), Test Type, Technology, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球大肠桿菌检测市场预计在 2025 年达到 24.7 亿美元，到 2032 年将达到 43.7 亿美元，预测期内的复合年增长率为 8.5%。

大肠桿菌检测是指检测水、食品或其他样本中的大肠桿菌，以确保安全和公共卫生的过程。它常用于环境监测、食品生产和临床检测，有助于识别可能导致疾病的污染。检测方法包括膜过滤、酵素连结免疫吸附试验和聚合酶链反应 (PCR)。准确的检测有助于快速回应和补救，并确保符合安全标准和法规，从而防止疫情爆发。

研究表明，TaqPath 面板的敏感性和特异性超过 98%，可确保您获得值得信赖的一致结果。

食物中毒增加

越来越多与受污染肉类、农产品和乳製品相关的疫情正在提高消费者和监管机构的意识。食品供应链的全球化进一步增加了大肠桿菌感染的风险，需要严格的检测通讯协定。都市化和饮食习惯的改变（例如已调理食品消费量的增加）也加剧了风险。为此，各国政府正在加强监管，强制要求定期进行微生物检测，而食品製造商也正在投资先进的检测技术。总体而言，这些趋势正在推动各行各业对有效的大肠桿菌检测解决方案的需求。

先进测试技术高成本

PCR和DNA检测等先进的诊断方法需要昂贵的设备、熟练的技术人员以及持续的维护，这使得中小型食品製造商难以获得这些方法。这些经济障碍阻碍了这些方法的广泛应用，尤其是在医疗基础设施和资金有限的开发中地区。此外，持续遵守严格的安全法规的成本也给企业带来了负担，阻碍了它们投资尖端检测解决方案。因此，许多公司依赖传统的、灵敏度较低的检测方法，这可能会削弱大肠桿菌检测的有效性，并减缓整体市场的成长。

提高医疗保健意识

严格的政府政策和国际卫生倡议强调卫生和食品安全的重要性，并提倡定期检测。技术进步使大肠桿菌诊断工具更快、更准确、可得性，促进了其广泛应用。此外，媒体关注度和公众宣导活动的不断提高，也造就了注重健康的消费者群体。同时，新兴国家医疗基础设施的不断扩展，也使得检测方法在临床、环境和食品产业中广泛应用。

缺乏熟练的专业人员和训练有素的人员

准确的检测需要掌握操作先进诊断设备和解读复杂结果的专业知识，而这在许多地区，尤其是新兴国家，都十分匮乏。这种人才短缺限制了先进检测技术的采用，并影响了大肠桿菌检测的整体品质和可靠性。此外，训练不足阻碍了标准化检测通讯协定的实施，导致结果不一致。合格人员的缺乏限制了市场的成长，因为它加剧了对传统方法的依赖，减慢了检测流程，并降低了大肠桿菌检测服务的效率和扩充性。

COVID-19的影响：

新冠疫情最初扰乱了大肠桿菌检测市场，原因是医疗资源转移、实验室关闭以及供应链中断，人们的注意力转向了病毒预防。在许多地区，常规食品安全和环境检测被推迟或被降级。然而，这场疫情也提高了全球对感染疾病风险的认识，并凸显了快速诊断的重要性。这导致对检测基础设施和卫生通讯协定的投资增加，最终增强了对可靠大肠桿菌检测解决方案的长期需求。

临床测试部分预计将成为预测期内最大的部分

由于大肠桿菌相关感染疾病率不断上升，尤其是在儿童和老年人等弱势群体中，临床检测领域预计将在预测期内占据最大的市场占有率。胃肠道感染疾病住院人数的增加推动了对准确及时诊断的需求。分子诊断技术的进步以及人们对抗菌素抗药性认识的不断提高，进一步鼓励医疗保健提供者采用准确的实验室检测方法，以有效管理患者并控制感染。

预计在预测期内，医院和诊所部门的复合年增长率最高。

预计医院和诊所细分市场将在预测期内实现最高成长率，这得益于患者入院人数的增加，尤其是在急诊和小儿科，以及对快速准确诊断的需求不断增长。分子PCR检测板和人工智慧增强型工作流程的采用，可以加快治疗决策的速度。此外，临床环境中的感染控制通讯协定和抗生素管理计画也进一步鼓励定期筛检大肠桿菌，以预防疫情爆发并改善病患预后。

比最大的地区

预计亚太地区将在预测期内占据最大的市场占有率，这得益于人们对食品安全的日益关注、医疗保健体系的不断完善以及公众对水传播感染疾病认识的不断提高。中国和印度等国家的城市人口成长和人口结构变化正在推动对高效诊断工具的需求。政府的支援政策和健康宣传活动鼓励定期检测，而PCR和生物感测器技术的创新正在提高检测速度和准确性，从而促进其在医疗保健和环境领域的应用。

复合年增长率最高的地区：

预计北美在预测期内的复合年增长率最高。这得益于严格的食品安全法规、健全的医疗保健体係以及人们对微生物威胁日益增长的认识。频繁的污染事件和对快速诊断的需求，促使人们采用PCR和LAMP等尖端方法。虽然FDA等机构的监管标准很高，但食品製造和水资源管理等关键产业也注重持续监测，以维护食品安全并保护消费者。

免费客製化服务：

此报告的订阅者可以从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 二手研究资料
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球大肠桿菌检测市场（按产品）

  • 耗材
  • 装置
  • 其他产品

6. 全球大肠桿菌检测市场（依检测类型）

  • 环境检查
    • 水质检测
      • 薄膜过滤
      • 多管发酵（MTF）
      • 酵素基材法
    • 食品和饮料检验
    • 动物饲料和牲畜检验
  • 实验室检查
    • 聚合酵素链锁反应（PCR）
    • 酵素免疫分析法（EIA）
    • 基于文化的方法
    • 快速诊断测试
    • 分子检测
  • 其他类型的测试

7. 全球大肠桿菌检测市场（依技术）

  • 生物感测器
  • 层析法平台
  • 质谱仪系统
  • 凝胶微滴法
  • 动态光散射
  • 流式细胞技术
  • 诊断影像
  • 其他技术

8. 全球大肠桿菌检测市场（依最终用户）

  • 诊断实验室
  • 医院和诊所
  • 食品加工公司
  • 水和污水处理
  • 政府和公共卫生机构
  • 研究和学术机构
  • 医生诊所
  • 其他最终用户

9. 全球大肠桿菌检测市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要发展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Abbott Laboratories
  • Siemens
  • Beckman Coulter
  • Hoffmann-La Roche
  • Wako
  • Cepheid
  • Becton, Dickinson and Company
  • Johnson & Johnson
  • Affymetrix
  • Novartis
  • bioMerieux
  • Olympus
  • Bio-Rad Laboratories
  • GenBio
  • Thermo Fisher Scientific
Product Code: SMRC30133

According to Stratistics MRC, the Global E-coli Testing Market is accounted for $2.47 billion in 2025 and is expected to reach $4.37 billion by 2032 growing at a CAGR of 8.5% during the forecast period. E-coli testing is the process of detecting Escherichia coli bacteria in water, food, or other samples to ensure safety and public health. Commonly used in environmental monitoring, food production, and clinical labs, it helps identify contamination that may lead to illness. Techniques include membrane filtration, enzyme-based assays, and PCR methods. Accurate testing prevents outbreaks by allowing quick response and remediation, ensuring compliance with safety standards and regulations.

According to a research article, the TaqPath panel provides sensitivity and specificity of over 98%, ensuring that the results are always dependable.

Market Dynamics:

Driver:

Rising incidence of foodborne illnesses

Increased outbreaks linked to contaminated meat, produce, and dairy products have heightened awareness among consumers and regulatory bodies. Globalization of the food supply chain further amplifies the risk of E. coli transmission, requiring stringent testing protocols. Urbanization and changing dietary habits, such as higher consumption of ready-to-eat foods, also contribute to the risk. In response, governments are enforcing stricter regulations and mandating routine microbial testing, while food producers invest in advanced detection technologies. These trends collectively propel the demand for effective E-coli testing solutions across various sectors.

Restraint:

High cost of advanced testing technologies

Sophisticated diagnostic methods, such as PCR and DNA-based assays, require expensive equipment, skilled technicians, and ongoing maintenance, making them less accessible to small and medium-sized food producers. These financial barriers hinder widespread adoption, especially in developing regions with limited healthcare infrastructure and funding. Additionally, the cost of continuous compliance with stringent safety regulations can be burdensome for businesses, reducing their willingness to invest in cutting-edge testing solutions. As a result, many organizations rely on traditional, less sensitive methods, potentially compromising the effectiveness of E. coli detection and slowing overall market growth.

Opportunity:

Increasing healthcare awareness

Strict government policies and international health initiatives stress the significance of hygiene and food safety, promoting regular testing practices. Advances in technology have improved the speed, accuracy, and availability of E. coli diagnostic tools, encouraging wider use. Moreover, greater media attention and public education efforts have led consumers to place more value on their health. At the same time, the expansion of healthcare infrastructure in developing countries is enabling broader adoption of testing procedures across clinical, environmental, and food industry applications.

Threat:

Lack of skilled professionals and trained personnel

Accurate testing requires expertise in handling advanced diagnostic equipment and interpreting complex results, which many regions, especially developing countries, lack. This shortage limits the adoption of sophisticated testing technologies and affects the overall quality and reliability of E-coli detection. Additionally, inadequate training hampers the implementation of standardized testing protocols, leading to inconsistent outcomes. The scarcity of qualified staff increases dependency on traditional methods, slows down testing processes, and restricts market growth by reducing the efficiency and scalability of E-coli testing services.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted the E. coli testing market due to diverted healthcare resources, lab closures, and supply chain interruptions, as focus shifted to combating the virus. Routine food safety and environmental testing were delayed or deprioritized in many regions. However, the pandemic also heightened global awareness of infectious disease risks and emphasized the importance of rapid diagnostics. This led to increased investment in testing infrastructure and hygiene protocols, ultimately strengthening long-term demand for reliable E-coli testing solutions.

The clinical testing segment is expected to be the largest during the forecast period

The clinical testing segment is expected to account for the largest market share during the forecast period, due to the rising incidence of E. coli-related infections, particularly in vulnerable populations such as children and the elderly. Increased hospital admissions linked to gastrointestinal illnesses have heightened the need for accurate and timely diagnosis. Advancements in molecular diagnostics and growing awareness of antimicrobial resistance further push healthcare providers to adopt precise clinical testing methods for effective patient management and infection control.

The hospitals & clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals & clinics segment is predicted to witness the highest growth rate, due to rising patient admissions, especially in emergency and pediatric departments, increase demand for rapid and accurate diagnostics. Adoption of molecular PCR panels and AI-enhanced workflows enables faster treatment decisions. Additionally, infection control protocols and antimicrobial stewardship programs in clinical settings further promote routine E. coli screening to prevent outbreaks and improve patient outcomes.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by increasing concerns about food safety, improved healthcare systems, and growing public awareness of waterborne illnesses. Rising urban populations and demographic shifts in nations like China and India have increased the need for efficient diagnostic tools. Supportive government policies and health campaigns encourage regular testing, while innovations in PCR and biosensor technologies enhance speed and precision, boosting uptake in both medical and environmental applications.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strict food safety laws, robust healthcare systems, and growing awareness of microbial threats. Recurring contamination events and the need for swift diagnostics have spurred the uptake of cutting-edge methods such as PCR and LAMP. Oversight by agencies like the FDA maintains high regulatory benchmarks, while key sectors like food manufacturing and water management focus on continuous monitoring to uphold safety and protect consumers.

Key players in the market

Some of the key players in E-coli Testing Market include Abbott Laboratories, Siemens, Beckman Coulter, Hoffmann-La Roche, Wako, Cepheid, Becton, Dickinson and Company, Johnson & Johnson, Affymetrix, Novartis, bioMerieux, Olympus, Bio-Rad Laboratories, GenBio, and Thermo Fisher Scientific.

Key Developments:

In July 2025, Siemens Smart Infrastructure announced a collaboration agreement with Microsoft to transform access to Internet of Things (IoT) data for buildings. The collaboration will enable interoperability between Siemens' digital building platform, Building X, and Microsoft Azure IoT Operations enabled by Azure Arc.

In March 2025, Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the U.S. Food and Drug Administration. The DxC 500i combines advanced technology with an intuitive user interface, ensuring that laboratories of all sizes can meet the growing demands of modern healthcare.

In February 2025, Abbott expands longstanding partnership with shedd aquarium through $10 million donation. Abbott and Shedd Aquarium are announcing a $10 million pledge from Abbott and Abbott's philanthropic foundation, Abbott Fund. The investment cements the longstanding partnership between Shedd, Abbott, and Abbott Fund to enrich the cultural, educational and environmental fabric of Chicago and spark passion for protecting the ocean environment.

Products Covered:

  • Consumables
  • Instruments
  • Other Products

Test Types Covered:

  • Environmental Testing
  • Clinical Testing
  • Other Test Types

Technologies Covered:

  • Biosensors
  • Chromatography Platforms
  • Mass Spectrometry Systems
  • Gel Micro Droplets
  • Differential Light Scattering
  • Flow Cytometry
  • Diagnostic Imaging
  • Other Technologies

End Users Covered:

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Food Processing Companies
  • Water Utilities & Wastewater Treatment
  • Government & Public Health Agencies
  • Research & Academic Institutions
  • Physicians' Offices
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global E-coli Testing Market, By Product

  • 5.1 Introduction
  • 5.2 Consumables
  • 5.3 Instruments
  • 5.4 Other Products

6 Global E-coli Testing Market, By Test Type

  • 6.1 Introduction
  • 6.2 Environmental Testing
    • 6.2.1 Water Testing
      • 6.2.1.1 Membrane Filtration
      • 6.2.1.2 Multiple Tube Fermentation (MTF)
      • 6.2.1.3 Enzyme Substrate Methods
    • 6.2.2 Food & Beverage Testing
    • 6.2.3 Animal Feed & Livestock Testing
  • 6.3 Clinical Testing
    • 6.3.1 Polymerase Chain Reaction (PCR)
    • 6.3.2 Enzyme Immunoassays (EIAs)
    • 6.3.3 Culture-Based Methods
    • 6.3.4 Rapid Diagnostic Tests
    • 6.3.5 Molecular Assays
  • 6.4 Other Test Types

7 Global E-coli Testing Market, By Technology

  • 7.1 Introduction
  • 7.2 Biosensors
  • 7.3 Chromatography Platforms
  • 7.4 Mass Spectrometry Systems
  • 7.5 Gel Micro Droplets
  • 7.6 Differential Light Scattering
  • 7.7 Flow Cytometry
  • 7.8 Diagnostic Imaging
  • 7.9 Other Technologies

8 Global E-coli Testing Market, By End User

  • 8.1 Introduction
  • 8.2 Diagnostic Laboratories
  • 8.3 Hospitals & Clinics
  • 8.4 Food Processing Companies
  • 8.5 Water Utilities & Wastewater Treatment
  • 8.6 Government & Public Health Agencies
  • 8.7 Research & Academic Institutions
  • 8.8 Physicians' Offices
  • 8.9 Other End Users

9 Global E-coli Testing Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Laboratories
  • 11.2 Siemens
  • 11.3 Beckman Coulter
  • 11.4 Hoffmann-La Roche
  • 11.5 Wako
  • 11.6 Cepheid
  • 11.7 Becton, Dickinson and Company
  • 11.8 Johnson & Johnson
  • 11.9 Affymetrix
  • 11.10 Novartis
  • 11.11 bioMerieux
  • 11.12 Olympus
  • 11.13 Bio-Rad Laboratories
  • 11.14 GenBio
  • 11.15 Thermo Fisher Scientific

List of Tables

  • Table 1 Global E-coli Testing Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global E-coli Testing Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global E-coli Testing Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 4 Global E-coli Testing Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 5 Global E-coli Testing Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 6 Global E-coli Testing Market Outlook, By Test Type (2024-2032) ($MN)
  • Table 7 Global E-coli Testing Market Outlook, By Environmental Testing (2024-2032) ($MN)
  • Table 8 Global E-coli Testing Market Outlook, By Water Testing (2024-2032) ($MN)
  • Table 9 Global E-coli Testing Market Outlook, By Membrane Filtration (2024-2032) ($MN)
  • Table 10 Global E-coli Testing Market Outlook, By Multiple Tube Fermentation (MTF) (2024-2032) ($MN)
  • Table 11 Global E-coli Testing Market Outlook, By Enzyme Substrate Methods (2024-2032) ($MN)
  • Table 12 Global E-coli Testing Market Outlook, By Food & Beverage Testing (2024-2032) ($MN)
  • Table 13 Global E-coli Testing Market Outlook, By Animal Feed & Livestock Testing (2024-2032) ($MN)
  • Table 14 Global E-coli Testing Market Outlook, By Clinical Testing (2024-2032) ($MN)
  • Table 15 Global E-coli Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2024-2032) ($MN)
  • Table 16 Global E-coli Testing Market Outlook, By Enzyme Immunoassays (EIAs) (2024-2032) ($MN)
  • Table 17 Global E-coli Testing Market Outlook, By Culture-Based Methods (2024-2032) ($MN)
  • Table 18 Global E-coli Testing Market Outlook, By Rapid Diagnostic Tests (2024-2032) ($MN)
  • Table 19 Global E-coli Testing Market Outlook, By Molecular Assays (2024-2032) ($MN)
  • Table 20 Global E-coli Testing Market Outlook, By Other Test Types (2024-2032) ($MN)
  • Table 21 Global E-coli Testing Market Outlook, By Technology (2024-2032) ($MN)
  • Table 22 Global E-coli Testing Market Outlook, By Biosensors (2024-2032) ($MN)
  • Table 23 Global E-coli Testing Market Outlook, By Chromatography Platforms (2024-2032) ($MN)
  • Table 24 Global E-coli Testing Market Outlook, By Mass Spectrometry Systems (2024-2032) ($MN)
  • Table 25 Global E-coli Testing Market Outlook, By Gel Micro Droplets (2024-2032) ($MN)
  • Table 26 Global E-coli Testing Market Outlook, By Differential Light Scattering (2024-2032) ($MN)
  • Table 27 Global E-coli Testing Market Outlook, By Flow Cytometry (2024-2032) ($MN)
  • Table 28 Global E-coli Testing Market Outlook, By Diagnostic Imaging (2024-2032) ($MN)
  • Table 29 Global E-coli Testing Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 30 Global E-coli Testing Market Outlook, By End User (2024-2032) ($MN)
  • Table 31 Global E-coli Testing Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 32 Global E-coli Testing Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 33 Global E-coli Testing Market Outlook, By Food Processing Companies (2024-2032) ($MN)
  • Table 34 Global E-coli Testing Market Outlook, By Water Utilities & Wastewater Treatment (2024-2032) ($MN)
  • Table 35 Global E-coli Testing Market Outlook, By Government & Public Health Agencies (2024-2032) ($MN)
  • Table 36 Global E-coli Testing Market Outlook, By Research & Academic Institutions (2024-2032) ($MN)
  • Table 37 Global E-coli Testing Market Outlook, By Physicians' Offices (2024-2032) ($MN)
  • Table 38 Global E-coli Testing Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.